JP2007500747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500747A5 JP2007500747A5 JP2006533125A JP2006533125A JP2007500747A5 JP 2007500747 A5 JP2007500747 A5 JP 2007500747A5 JP 2006533125 A JP2006533125 A JP 2006533125A JP 2006533125 A JP2006533125 A JP 2006533125A JP 2007500747 A5 JP2007500747 A5 JP 2007500747A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- side chain
- replaced
- pharmaceutical composition
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 40
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 22
- 150000001413 amino acids Chemical class 0.000 claims 21
- 235000018102 proteins Nutrition 0.000 claims 20
- 102000004169 proteins and genes Human genes 0.000 claims 20
- 108090000623 proteins and genes Proteins 0.000 claims 20
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 19
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 18
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical compound O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 claims 18
- 229940024606 amino acid Drugs 0.000 claims 17
- 235000001014 amino acid Nutrition 0.000 claims 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 17
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims 12
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 11
- 235000004279 alanine Nutrition 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 125000002877 alkyl aryl group Chemical group 0.000 claims 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- 239000004471 Glycine Substances 0.000 claims 9
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 9
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 9
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 9
- 239000004472 Lysine Substances 0.000 claims 9
- 235000018977 lysine Nutrition 0.000 claims 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 9
- 239000004475 Arginine Substances 0.000 claims 8
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 8
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 8
- 241001465754 Metazoa Species 0.000 claims 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 8
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 8
- 229960002591 hydroxyproline Drugs 0.000 claims 8
- 229930182817 methionine Natural products 0.000 claims 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 8
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 8
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 7
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 claims 7
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 7
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 claims 7
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 7
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 7
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 7
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 7
- 235000009582 asparagine Nutrition 0.000 claims 7
- 229960001230 asparagine Drugs 0.000 claims 7
- 235000003704 aspartic acid Nutrition 0.000 claims 7
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 7
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 7
- 235000004554 glutamine Nutrition 0.000 claims 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 7
- 229960000310 isoleucine Drugs 0.000 claims 7
- 229960003104 ornithine Drugs 0.000 claims 7
- 239000004474 valine Substances 0.000 claims 7
- SXGMVGOVILIERA-UHFFFAOYSA-N 2,3-diaminobutanoic acid Chemical compound CC(N)C(N)C(O)=O SXGMVGOVILIERA-UHFFFAOYSA-N 0.000 claims 6
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims 6
- 102000009027 Albumins Human genes 0.000 claims 6
- 108010088751 Albumins Proteins 0.000 claims 6
- 102000003951 Erythropoietin Human genes 0.000 claims 6
- 108090000394 Erythropoietin Proteins 0.000 claims 6
- 108060003951 Immunoglobulin Proteins 0.000 claims 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 6
- 210000001744 T-lymphocyte Anatomy 0.000 claims 6
- 229940105423 erythropoietin Drugs 0.000 claims 6
- 102000018358 immunoglobulin Human genes 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 6
- 108090000790 Enzymes Proteins 0.000 claims 5
- 102000004190 Enzymes Human genes 0.000 claims 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 4
- 235000013922 glutamic acid Nutrition 0.000 claims 4
- 239000004220 glutamic acid Substances 0.000 claims 4
- 230000002209 hydrophobic effect Effects 0.000 claims 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 3
- CMUHFUGDYMFHEI-QMMMGPOBSA-N 4-amino-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N)C=C1 CMUHFUGDYMFHEI-QMMMGPOBSA-N 0.000 claims 3
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 claims 3
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims 3
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 3
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 claims 3
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 3
- 239000004473 Threonine Substances 0.000 claims 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 3
- 235000013477 citrulline Nutrition 0.000 claims 3
- 229960002173 citrulline Drugs 0.000 claims 3
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims 3
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 3
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims 3
- 235000008521 threonine Nutrition 0.000 claims 3
- 229940034208 thyroxine Drugs 0.000 claims 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 claims 3
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 claims 2
- 102000005367 Carboxypeptidases Human genes 0.000 claims 2
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 claims 2
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 2
- 230000006044 T cell activation Effects 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 108010083141 dipeptidyl carboxypeptidase Proteins 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 229960004452 methionine Drugs 0.000 claims 2
- 229960001639 penicillamine Drugs 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 125000000981 3-amino-3-oxopropyl group Chemical group [H]C([*])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 1
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 claims 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 claims 1
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010069002 Autoimmune pancreatitis Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000001204 Hashimoto Disease Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 102000003839 Human Proteins Human genes 0.000 claims 1
- 108090000144 Human Proteins Proteins 0.000 claims 1
- 206010020850 Hyperthyroidism Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 206010029240 Neuritis Diseases 0.000 claims 1
- 206010034277 Pemphigoid Diseases 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 206010047642 Vitiligo Diseases 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 208000010928 autoimmune thyroid disease Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 208000005987 polymyositis Diseases 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47101703P | 2003-05-15 | 2003-05-15 | |
| US48927003P | 2003-07-21 | 2003-07-21 | |
| US51493003P | 2003-10-27 | 2003-10-27 | |
| US51733803P | 2003-11-04 | 2003-11-04 | |
| PCT/US2004/015340 WO2004103304A2 (en) | 2003-05-15 | 2004-05-14 | Treatment of t-cell mediated diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010292763A Division JP2011102309A (ja) | 2003-05-15 | 2010-12-28 | Ｔ細胞媒介性疾患の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007500747A JP2007500747A (ja) | 2007-01-18 |
| JP2007500747A5 true JP2007500747A5 (enExample) | 2007-06-28 |
Family
ID=33479817
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533125A Pending JP2007500747A (ja) | 2003-05-15 | 2004-05-14 | Ｔ細胞媒介性疾患の処置 |
| JP2010292763A Pending JP2011102309A (ja) | 2003-05-15 | 2010-12-28 | Ｔ細胞媒介性疾患の処置 |
| JP2014093779A Expired - Fee Related JP6102822B2 (ja) | 2003-05-15 | 2014-04-30 | Ｔ細胞媒介性疾患の処置 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010292763A Pending JP2011102309A (ja) | 2003-05-15 | 2010-12-28 | Ｔ細胞媒介性疾患の処置 |
| JP2014093779A Expired - Fee Related JP6102822B2 (ja) | 2003-05-15 | 2014-04-30 | Ｔ細胞媒介性疾患の処置 |
Country Status (16)
| Country | Link |
|---|---|
| US (15) | US7732403B2 (enExample) |
| EP (7) | EP2517719B1 (enExample) |
| JP (3) | JP2007500747A (enExample) |
| KR (5) | KR20120101164A (enExample) |
| CN (7) | CN103191409A (enExample) |
| AU (2) | AU2004241101B2 (enExample) |
| CA (2) | CA2523467C (enExample) |
| DK (1) | DK2537524T3 (enExample) |
| ES (5) | ES2572454T3 (enExample) |
| HK (2) | HK1203056A1 (enExample) |
| HU (1) | HUE031620T2 (enExample) |
| IL (3) | IL171961A (enExample) |
| NZ (2) | NZ542886A (enExample) |
| PL (1) | PL2537524T3 (enExample) |
| PT (1) | PT2537524T (enExample) |
| WO (1) | WO2004103304A2 (enExample) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1808438B1 (en) | 1999-06-29 | 2014-10-01 | MannKind Corporation | Purification and stabilization of peptide and proteins in pharmaceutical agents |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| AU7931301A (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
| ES2425392T3 (es) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartucho para un aparato de inhalación |
| JP4674317B2 (ja) * | 2002-10-02 | 2011-04-20 | ディエムアイ アクイジション コーポレイション | 疾病の判定および監視 |
| PL2537524T3 (pl) | 2003-05-15 | 2017-01-31 | Ampio Pharmaceuticals, Inc. | Leczenie chorób mediowanych przez komórki T |
| DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
| BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
| WO2007033372A2 (en) | 2005-09-14 | 2007-03-22 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| DK1986679T3 (da) | 2006-02-22 | 2017-11-20 | Mannkind Corp | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof |
| WO2008014613A1 (en) * | 2006-08-04 | 2008-02-07 | Manus Pharmaceuticals (Canada) Ltd. | Multifunctional bioactive compounds |
| US8039505B2 (en) * | 2007-04-11 | 2011-10-18 | University Of Utah Research Foundation | Compounds for modulating T-cells |
| KR20100090692A (ko) * | 2007-10-24 | 2010-08-16 | 맨카인드 코포레이션 | 활성제의 전달 |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| EP2300011A4 (en) * | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | THERAPEUTIC PROCESSES AND COMPOUNDS |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CA3153292A1 (en) | 2008-06-13 | 2009-12-17 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
| CN102065942B (zh) | 2008-06-20 | 2013-12-11 | 曼金德公司 | 用于对吸入工作进行实时描绘的交互式设备和方法 |
| TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| ES2342997B1 (es) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
| KR20180036807A (ko) | 2009-06-12 | 2018-04-09 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| US20120058934A1 (en) * | 2010-09-07 | 2012-03-08 | Dmi Acquisition Corp. | Treatment of diseases |
| JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
| KR101156666B1 (ko) * | 2010-09-17 | 2012-06-15 | 대한민국(농촌진흥청장) | 신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물 |
| KR101940832B1 (ko) | 2011-04-01 | 2019-01-21 | 맨카인드 코포레이션 | 의약 카트리지용 블리스터 패키지 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| AU2012323320B2 (en) | 2011-10-10 | 2017-05-11 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
| AU2012328605B9 (en) | 2011-10-28 | 2017-08-03 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| CN104619369B (zh) | 2012-07-12 | 2018-01-30 | 曼金德公司 | 干粉药物输送系统和方法 |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| BR112015017958A2 (pt) * | 2013-02-01 | 2017-07-11 | Ampio Pharmaceuticals Inc | métodos para produzir dicetopiperazinas e composições contendo dicetopiperazinas |
| AU2014228415B2 (en) | 2013-03-15 | 2018-08-09 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| WO2014145729A2 (en) * | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| AU2014386720B2 (en) * | 2014-06-20 | 2016-07-21 | Suntory Holdings Limited | Uric acid-lowering agent |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| WO2016209969A1 (en) * | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| WO2017002786A1 (ja) * | 2015-07-02 | 2017-01-05 | サントリーホールディングス株式会社 | Ｇｌｐ－２分泌促進用組成物 |
| US10397652B2 (en) * | 2016-05-18 | 2019-08-27 | Rovi Guides, Inc. | Recommending a location based on quality of service at a location |
| CN107311943A (zh) * | 2017-07-05 | 2017-11-03 | 四川好医生攀西药业有限责任公司 | 一种促进血管生成的环二肽及其制备方法 |
| US11403132B2 (en) | 2017-07-11 | 2022-08-02 | Red Hat, Inc. | Managing tasks in a cloud computing environment using multiple orchestration tools |
| TWI644680B (zh) * | 2017-12-15 | 2018-12-21 | 長庚生物科技股份有限公司 | 環狀酪氨酸－纈氨酸及其類似物用於治療氣喘及呼吸道過敏之用途 |
| KR102140910B1 (ko) * | 2019-03-28 | 2020-08-04 | 주식회사 노브메타파마 | Chp(사이클로-히스프로)를 포함하는 섬유증의 예방, 개선 또는 치료용 조성물 |
| WO2021195265A1 (en) | 2020-03-24 | 2021-09-30 | Ampio Pharmaceuticals, Inc. | Methods for treating diseases associated with respiratory viruses |
| CN115006553B (zh) * | 2020-05-11 | 2024-01-05 | 中国药科大学 | 用于制备肿瘤诊断显像剂的多肽及其应用 |
| US12053467B2 (en) | 2020-12-18 | 2024-08-06 | NovMeta Pharma Co., Ltd. | Method of treating fibrosis |
| CN113754598B (zh) * | 2021-09-29 | 2023-06-06 | 四川大学 | 含环肽结构的二胺、聚酰亚胺及其制备方法 |
Family Cites Families (222)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1003976A (en) | 1909-01-04 | 1911-09-26 | Alfred Bode | Winding mechanism for electric jib-cranes. |
| US1025193A (en) | 1911-03-01 | 1912-05-07 | Oliver Jefferson Kennedy | Foldable holder for writing-pads. |
| US1034279A (en) | 1911-03-13 | 1912-07-30 | John H Munson | Automatic belt guide and thrower. |
| US3941790A (en) | 1967-07-03 | 1976-03-02 | National Research Development Corporation | Bis diketopiperazines |
| BE765030A (fr) | 1970-04-02 | 1971-08-16 | Snam Progetti | Composes contenant un noyau de dicetopiperazine et leur procedede fabrication |
| GB1353304A (en) * | 1971-03-30 | 1974-05-15 | Sagami Chem Res | Process for production of diketopiperazine dihydroxamates and intermediate therefor |
| US4006261A (en) * | 1973-09-28 | 1977-02-01 | Firmenich S.A. | Flavoring with mixtures of theobromine and cyclic dipeptides |
| US3928330A (en) | 1973-12-19 | 1975-12-23 | Ciba Geigy Corp | Substituted piperazinedione carboxylic acids and metal salts thereof |
| FR2264350B1 (enExample) * | 1974-03-11 | 1978-09-29 | Cii | |
| GB1459488A (en) | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
| US4088649A (en) | 1975-07-02 | 1978-05-09 | Firmenich S.A. | Process for preparing a diketo-piperazine |
| JPS5225019A (en) | 1975-08-19 | 1977-02-24 | New Zealand Inventions Dev | Production of serum albumin |
| US4205057A (en) | 1978-01-17 | 1980-05-27 | Government Of The United States | Cerebrospinal fluid protein fragments |
| JPS55144675A (en) | 1979-04-28 | 1980-11-11 | Yazaki Corp | Rockable nozzle for electric wire supply device |
| JPS6236331Y2 (enExample) | 1979-05-16 | 1987-09-16 | ||
| DE2940654A1 (de) | 1979-10-06 | 1981-04-16 | Bayer Ag, 5090 Leverkusen | Dimeres keten der 1,2,,-triazol-3-carbonsaeure |
| US4331595A (en) * | 1980-06-23 | 1982-05-25 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
| US4289759A (en) | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
| JPS5836225U (ja) | 1981-08-31 | 1983-03-09 | 株式会社東芝 | 金属製平パレツト |
| JPS5973574A (ja) | 1982-10-21 | 1984-04-25 | Grelan Pharmaceut Co Ltd | 環状ジペプチド類 |
| JPS5973574U (ja) | 1982-11-10 | 1984-05-18 | 三菱自動車工業株式会社 | 電磁式燃料噴射装置 |
| US4694061A (en) | 1983-10-12 | 1987-09-15 | Ciba-Geigy Corporation | Radiation-sensitive polycondensates, processes for their preparation coated material and its use |
| US4656190A (en) | 1983-11-14 | 1987-04-07 | Merck & Co., Inc. | Indene derivatives and their use as PAF-antagonists |
| NZ212051A (en) * | 1984-05-18 | 1988-10-28 | Univ Australian | Immune response suppression; certain epipolythio- dioxopiperazine derivatives and their preparation |
| DE3435972A1 (de) | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| JPS61112060A (ja) | 1984-11-02 | 1986-05-30 | Fujisawa Pharmaceut Co Ltd | ピペラジン化合物 |
| US4806538A (en) | 1984-11-02 | 1989-02-21 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine compound as PAF-antagonist |
| JPH0245309Y2 (enExample) | 1984-12-21 | 1990-11-30 | ||
| CS254868B1 (cs) * | 1985-06-11 | 1988-02-15 | Jiri Vanzura | Způsob výroby cyklických dipeptidů |
| JPS6236331A (ja) | 1985-08-12 | 1987-02-17 | Kenji Suzuki | 抗感染症剤ならびに免疫賦活剤 |
| US4771056A (en) | 1985-08-29 | 1988-09-13 | Roman Rozencwaig | Method of medical treatment with serotonin antagonists |
| US4661500A (en) | 1985-08-29 | 1987-04-28 | Roman Rozencwaig | Method of medical treatment with serotonin antagonists |
| US5047401A (en) | 1985-09-09 | 1991-09-10 | Board Of Regents, The University Of Texas System | Use of dipeptide alkyl esters to treat GVHD |
| US4694081A (en) | 1985-09-23 | 1987-09-15 | Monsanto Company | Process to prepare 2,5-diketopiperazines |
| PT83613B (en) | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
| JPS63290868A (ja) | 1987-05-22 | 1988-11-28 | Fujisawa Pharmaceut Co Ltd | ジケトピペラジン誘導体およびその塩類 |
| JPS6413075A (en) | 1987-07-03 | 1989-01-17 | Nippon Chemiphar Co | Production of 2, 5-piperazinedione derivative |
| US5512544A (en) * | 1987-09-13 | 1996-04-30 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising an anticytokine |
| MY104933A (en) | 1987-09-30 | 1994-07-30 | Pfizer Ltd | Platelet activating factor antagonists |
| US5144073A (en) | 1988-08-31 | 1992-09-01 | Hubbs John C | Process for preparation of dipeptides |
| US4992552A (en) | 1988-08-31 | 1991-02-12 | Eastman Kodak Company | Process for preparation of amino acids |
| JP2001055340A (ja) | 1988-10-31 | 2001-02-27 | Welfide Corp | アルブミン製剤の製造方法 |
| US5238938A (en) * | 1989-02-10 | 1993-08-24 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives |
| DE3906952A1 (de) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel |
| US5902790A (en) | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| ES2070878T3 (es) | 1989-10-13 | 1995-06-16 | Phobos Nv | Procedimiento para la produccion en continuo de resina de poliester de alto peso molecular. |
| JPH03176478A (ja) | 1989-12-05 | 1991-07-31 | Snow Brand Milk Prod Co Ltd | 新規なジケトピペラジン誘導体及びこれを有効成分とする免疫抑制剤 |
| WO1991014378A1 (en) | 1990-03-15 | 1991-10-03 | The Nutrasweet Company | Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor |
| US6180616B1 (en) | 1990-05-10 | 2001-01-30 | Atsuo F. Fukunaga | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
| US6099856A (en) | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
| US6331318B1 (en) * | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
| GB9022543D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
| JP2506541Y2 (ja) | 1990-10-31 | 1996-08-14 | エヌテイエヌ株式会社 | 軸受の潤滑装置 |
| AU646522B2 (en) | 1990-11-14 | 1994-02-24 | University Company Pty Limited, The | Diagnosis and treatment of multiple sclerosis |
| US5776892A (en) | 1990-12-21 | 1998-07-07 | Curative Health Services, Inc. | Anti-inflammatory peptides |
| JPH04234374A (ja) | 1990-12-27 | 1992-08-24 | Ajinomoto Co Inc | ジケトピペラジン誘導体の製造方法 |
| GB9102997D0 (en) | 1991-02-13 | 1991-03-27 | Pfizer Ltd | Therapeutic agents |
| US5543503A (en) * | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
| US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
| EP0614369B1 (en) | 1991-10-28 | 1999-12-29 | Cytran Ltd. | Pharmaceutical dipeptide compositions and methods of use thereof |
| JPH05244982A (ja) * | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| JPH05163148A (ja) | 1991-12-18 | 1993-06-29 | Kanebo Ltd | 抗腫瘍剤 |
| GB9200210D0 (en) * | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| DE4201147A1 (de) | 1992-01-17 | 1993-07-22 | Boehringer Ingelheim Kg | Verwendung von paf-antagonisten hetrazepinoider struktur zur behandlung der allergischen rhinitis und verwandter indikationen |
| US5352461A (en) | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| JP3176478B2 (ja) | 1992-05-29 | 2001-06-18 | いすゞ自動車株式会社 | 居眠り運転防止装置 |
| US5418218A (en) | 1992-07-10 | 1995-05-23 | The University Of Maryland At Baltimore | Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent |
| US5648486A (en) | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
| US5434151A (en) | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5463083A (en) | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5358938A (en) | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| GB9217331D0 (en) | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
| AU5016793A (en) | 1992-08-20 | 1994-03-15 | Cytomed, Inc | Dual functional anti-inflammatory and immunosuppressive agents |
| US5728553A (en) | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
| AU689091B2 (en) | 1992-12-18 | 1998-03-26 | Cell Med, Inc. | Assay and treatment for demyelinating diseases such as multiple sclerosis |
| ES2068742B1 (es) * | 1993-02-11 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de piridinio. |
| AU6359594A (en) | 1993-03-04 | 1994-09-26 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| US6107050A (en) | 1993-05-03 | 2000-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic test for alzheimers disease |
| WO1995003054A1 (en) * | 1993-07-23 | 1995-02-02 | Lxr Biotechnology Inc. | Methods of treating apoptosis and associated conditions |
| GB9324872D0 (en) | 1993-12-03 | 1994-01-19 | Univ Pasteur | Pharmaceutical compounds |
| IL112627A0 (en) | 1994-02-14 | 1995-05-26 | Xenova Ltd | Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them |
| JP2921731B2 (ja) | 1994-03-10 | 1999-07-19 | 日清製油株式会社 | 有機溶媒または油脂類のゲル化剤 |
| FR2717484A1 (fr) | 1994-03-16 | 1995-09-22 | Pf Medicament | Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant . |
| GB9410387D0 (en) | 1994-05-24 | 1994-07-13 | Xenova Ltd | Pharmaceutical compounds |
| US5550132A (en) * | 1994-06-22 | 1996-08-27 | University Of North Carolina | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| AU2871195A (en) | 1994-06-23 | 1996-01-19 | Affymax Technologies N.V. | Methods for the synthesis of diketopiperazines |
| US5817751A (en) | 1994-06-23 | 1998-10-06 | Affymax Technologies N.V. | Method for synthesis of diketopiperazine and diketomorpholine derivatives |
| US5990112A (en) | 1996-06-18 | 1999-11-23 | Affymax Technologies N.V. | Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use |
| US5792776A (en) | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| CZ372096A3 (cs) | 1994-06-27 | 1998-04-15 | Cytomed Inc. | Sloučeniny a metody léčby kardiovaskulárních, dýchacích a imunitních potíží |
| US5750565A (en) | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5703093A (en) | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| WO1996004268A1 (en) | 1994-07-29 | 1996-02-15 | Nikken Chemicals Co., Ltd. | 1,4-dihydropyridine compound and medicinal composition containing the same |
| US5561115A (en) | 1994-08-10 | 1996-10-01 | Bayer Corporation | Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| AU710339B2 (en) | 1994-10-05 | 1999-09-16 | Amarin Neuroscience Limited | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
| ES2087038B1 (es) | 1994-11-07 | 1997-03-16 | Uriach & Cia Sa J | Nuevas piperidinas con actividad antagonista del paf. |
| CZ280726B6 (cs) | 1994-11-16 | 1996-04-17 | Galena, A.S. | Pentapeptidické prekurzory biologicky účinných cyklických dipeptidů |
| WO1996016947A1 (en) | 1994-12-01 | 1996-06-06 | Toyama Chemical Co., Ltd. | Novel 2,3-diketopiperazine derivative or salt thereof |
| JP3634891B2 (ja) * | 1995-04-06 | 2005-03-30 | 株式会社海洋バイオテクノロジー研究所 | キチナーゼ阻害物質 |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| WO1997002289A1 (en) | 1995-07-06 | 1997-01-23 | Zeneca Limited | Peptide inhibitors of fibronectine |
| US5811241A (en) | 1995-09-13 | 1998-09-22 | Cortech, Inc. | Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones |
| US5665714A (en) | 1995-12-07 | 1997-09-09 | Clarion Pharmaceuticals Inc. | N-substituted glycerophosphoethanolamines |
| US6060452A (en) | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
| US6541224B2 (en) * | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
| CA2251464A1 (en) * | 1996-04-03 | 1997-10-16 | Pepresearch A/S | Non-dendritic backbone peptide carrier |
| US5919785A (en) | 1996-04-03 | 1999-07-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| WO1997036888A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6262119B1 (en) * | 1996-04-12 | 2001-07-17 | Peptide Technology Limited | Methods of treating immunopathologies using polyunsaturated fatty acids |
| US5932579A (en) | 1996-06-18 | 1999-08-03 | Affymax Technologies N.V. | Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use |
| US5985581A (en) | 1996-07-25 | 1999-11-16 | The Mclean Hospital Corporation | Use of presenilin-1 for diagnosis of alzheimers disease |
| AU4720397A (en) | 1996-09-09 | 1998-03-26 | Microbial Screening Technologies Pty. Limited | Terpenylated diketopiperazines, (drimentines) |
| NZ335544A (en) | 1996-10-04 | 2001-08-31 | Neuronz Ltd | Use of GPE (tripeptide or dipeptide) in form of Gly-Pro-Glu or Gly-Pro or Pro-Glu as a neuromodulator |
| RU2125728C1 (ru) | 1996-10-10 | 1999-01-27 | Пермская государственная медицинская академия | Способ иммунодиагностики рассеянного склероза |
| EP0835660A1 (en) | 1996-10-14 | 1998-04-15 | Gaston Edmond Filomena Merckx | Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions |
| US6441172B1 (en) | 1996-11-07 | 2002-08-27 | Torrey Pines Institute For Molecular Studies | Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| US6091737A (en) * | 1996-11-15 | 2000-07-18 | Multi-Tech Systems, Inc. | Remote communications server system |
| US5932112A (en) | 1996-11-27 | 1999-08-03 | Browning Transport Management, Inc. | Method and apparatus for killing microorganisms in ship ballast water |
| RU2112242C1 (ru) | 1996-12-09 | 1998-05-27 | Пермская государственная медицинская академия | Способ диагностики рассеянного склероза |
| JPH10226615A (ja) | 1997-02-18 | 1998-08-25 | Pola Chem Ind Inc | アスパラギン酸フェニルアラニン環状ジペプタイド誘導体を含有する組成物 |
| JPH10245315A (ja) | 1997-03-05 | 1998-09-14 | Pola Chem Ind Inc | シクロジペプタイド誘導体を含有する組成物 |
| US6306909B1 (en) | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| WO1998040748A1 (en) | 1997-03-14 | 1998-09-17 | Neuromark | Diagnosing neurologic disorders |
| US6265535B1 (en) | 1997-05-30 | 2001-07-24 | The Trustees Of The University Of Pennsylvania | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
| RU2128840C1 (ru) | 1997-06-16 | 1999-04-10 | Пермская государственная медицинская академия | Способ диагностики рассеянного склероза |
| US6222029B1 (en) * | 1997-08-01 | 2001-04-24 | Genset | 5′ ESTs for secreted proteins expressed in brain |
| US5834032A (en) | 1997-08-11 | 1998-11-10 | Song; Moon K. | Compositions and methods for treating diabetes |
| US5856950A (en) * | 1997-08-22 | 1999-01-05 | Micron Technology, Inc. | Cancellation of redundant elements with a cancel bank |
| US7202279B1 (en) | 1998-02-11 | 2007-04-10 | Georgetown University | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| EP0939124A3 (en) * | 1998-02-24 | 2001-03-21 | Smithkline Beecham Plc | MGBP1 sequences |
| AU3370099A (en) | 1998-03-31 | 1999-10-18 | Mayo Foundation For Medical Education And Research | Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation |
| EP1067951A2 (en) * | 1998-04-03 | 2001-01-17 | Cytran Ltd. | Use of l-glu-l-trp in the treatment of hiv infection |
| WO1999051720A2 (en) * | 1998-04-03 | 1999-10-14 | Cytran Ltd. | Methods for production of therapeutic cytokines |
| AU767241B2 (en) | 1998-09-14 | 2003-11-06 | Qiang Xu | Immunosuppressive agents |
| US6461875B1 (en) | 1998-10-02 | 2002-10-08 | Ischemia Technologies, Inc. | Test for rapid evaluation of ischemic states and kit |
| ATE401342T1 (de) | 1998-10-02 | 2008-08-15 | Ischemia Tech Inc | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden |
| US6492179B1 (en) | 1998-10-02 | 2002-12-10 | Ischemia Techologies, Inc. | Test for rapid evaluation of ischemic states and kit |
| WO2000020840A1 (en) | 1998-10-02 | 2000-04-13 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
| US6475743B1 (en) | 1998-10-02 | 2002-11-05 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
| DE19847690A1 (de) | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
| US7026322B2 (en) | 1998-11-12 | 2006-04-11 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| US6358957B1 (en) | 1998-11-12 | 2002-03-19 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| CA2359561A1 (en) * | 1999-01-20 | 2000-07-27 | Shiro Akinaga | Proteasome inhibitors |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| EP1166117A2 (en) | 1999-03-19 | 2002-01-02 | Vanderbilt University | Diagnosis and treatment of multiple sclerosis |
| US6090780A (en) | 1999-04-07 | 2000-07-18 | Chandon Prasad | Histidyl-proline diketopiperazine and method of use |
| US6689765B2 (en) | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| JP2000327575A (ja) | 1999-05-26 | 2000-11-28 | Teika Seiyaku Kk | ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体 |
| US6451224B1 (en) * | 1999-07-21 | 2002-09-17 | The Dow Chemical Company | Stable free-flowing solid chelants |
| DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
| EP1276731A2 (en) | 1999-11-12 | 2003-01-22 | Wyeth | Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht 1a activity |
| AU1624801A (en) | 1999-11-19 | 2001-05-30 | Corvas International, Inc. | Plasminogen activator inhibitor antagonists related applications |
| US20050096323A1 (en) | 1999-11-30 | 2005-05-05 | Novoscience Pharma Inc. | Diketopiperazine derivatives to inhibit thrombin |
| EP1260230A4 (en) | 2000-02-29 | 2008-08-06 | Chugai Pharmaceutical Co Ltd | LONG-TERM STABILIZED PREPARATIONS |
| DE10019879A1 (de) | 2000-04-20 | 2001-10-25 | Degussa | Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung |
| US7288545B2 (en) | 2000-05-09 | 2007-10-30 | Angiorx Corporation | Piperazinedione compounds |
| US6635649B2 (en) | 2000-05-09 | 2003-10-21 | Che-Ming Teng | Piperazinedione compounds |
| DE10026998A1 (de) | 2000-05-31 | 2001-12-13 | Fresenius Kabi De Gmbh | Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde |
| EP1289990A1 (en) | 2000-06-08 | 2003-03-12 | Lilly Icos LLC | Tetracyclic diketopierazine compounds as pdev inhibitors |
| US7175844B2 (en) | 2000-07-18 | 2007-02-13 | Joslin Diabetes Center, Inc. | Methods of modulating fibrosis |
| CZ20002680A3 (cs) | 2000-07-21 | 2002-03-13 | Ev®En Ing. Csc. Kasafírek | Cyklické alkylthiopeptidy |
| CZ20002681A3 (cs) | 2000-07-21 | 2002-03-13 | Ev®En Ing. Csc. Kasafírek | Cyklické tyrosinové dipeptidy |
| AU7931301A (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
| AU2001284697A1 (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
| US20070208087A1 (en) * | 2001-11-02 | 2007-09-06 | Sanders Virginia J | Compounds, compositions and methods for the treatment of inflammatory diseases |
| US6815214B2 (en) * | 2000-12-29 | 2004-11-09 | Celltech R & D, Inc. | Pharmaceutical uses and synthesis of diketopiperazines |
| GB2372740A (en) | 2001-01-17 | 2002-09-04 | Xenova Ltd | Diketopiperazines |
| AU2002225219A1 (en) | 2001-01-26 | 2002-08-06 | Oxford Glycosciences (Uk) Ltd | Diagnosis and treatment of multiple sclerosis |
| EP1372571A4 (en) | 2001-03-20 | 2006-06-07 | New Century Pharmaceuticals | METHOD AND COMPOSITIONS FOR OPTIMIZING THE STABILITY OF BLOOD AND TISSUES CONFERRED BY CAMPTOTHECIN AND OTHER THERAPEUTIC COMPOUNDS BINDING ALBUMIN |
| DE60214701T2 (de) * | 2001-04-13 | 2007-09-13 | Vertex Pharmaceuticals Inc., Cambridge | Inhibitoren von c-jun-n-terminalen-kinasen (jnk) und anderen proteinkinasen |
| EP1408986B1 (en) * | 2001-05-08 | 2008-09-24 | Yale University | Proteomimetic compounds and methods |
| US7368421B2 (en) | 2001-06-27 | 2008-05-06 | Probiodrug Ag | Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| WO2003032809A2 (en) | 2001-10-15 | 2003-04-24 | The Medstar Research Institute | Modulation of akt-dependent response to prevent restenosis |
| US20040063654A1 (en) * | 2001-11-02 | 2004-04-01 | Davis Mark E. | Methods and compositions for therapeutic use of RNA interference |
| WO2004033620A2 (en) * | 2001-11-02 | 2004-04-22 | Insert Therapeutics, Inc. | Methods and compositions for therapeutic use of rna interference |
| GB0128108D0 (en) | 2001-11-23 | 2002-01-16 | Astrazeneca Ab | Therapeutic use |
| JP4301003B2 (ja) | 2001-12-27 | 2009-07-22 | 味の素株式会社 | グルタミン酸誘導体の製造方法 |
| MXPA04006929A (es) | 2002-01-18 | 2004-12-06 | Unilever Nv | Composiciones cosmeticas comprendiendo un compuesto de ciclodipeptido. |
| US20030203915A1 (en) * | 2002-04-05 | 2003-10-30 | Xinqin Fang | Nitric oxide donors, compositions and methods of use related applications |
| ES2204294B2 (es) * | 2002-07-02 | 2005-02-01 | Universidade De Santiago De Compostela | Nuevos antibioticos activos frente al vibrio anguillarum y sus aplicaciones en cultivos de peces, crustaceos, moluscos y otras actividades de acuicultura. |
| US20080260838A1 (en) | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
| US20040038865A1 (en) * | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| IL166628A0 (en) | 2002-08-02 | 2006-01-15 | Nereus Pharmaceuticals Inc | Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof |
| KR20050042146A (ko) * | 2002-08-06 | 2005-05-04 | 아플라겐 게엠베하 | 결합 분자 |
| DE10238144A1 (de) | 2002-08-15 | 2004-02-26 | Basf Ag | Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen |
| JP4641796B2 (ja) | 2002-09-03 | 2011-03-02 | ジョージタウン ユニヴァーシティ | Ａｋｔ阻害剤、医薬組成物、及びその用途 |
| JP4674317B2 (ja) | 2002-10-02 | 2011-04-20 | ディエムアイ アクイジション コーポレイション | 疾病の判定および監視 |
| US7196169B2 (en) | 2002-10-11 | 2007-03-27 | Queen's University At Kingston | Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage |
| EP1572669A2 (en) | 2002-11-22 | 2005-09-14 | Novo Nordisk A/S | 2,5-diketopiperazines for the treatment of obesity |
| PL2537524T3 (pl) | 2003-05-15 | 2017-01-31 | Ampio Pharmaceuticals, Inc. | Leczenie chorób mediowanych przez komórki T |
| BRPI0412348A (pt) | 2003-07-30 | 2006-09-05 | Xenon Pharmaceuticals Inc | derivados de piperazina e seu uso como agentes terapêuticos |
| DK1664050T3 (en) | 2003-09-03 | 2016-03-07 | Neuren Pharmaceuticals Ltd | Neuroprotective bicyclic compounds and pharmaceutical compositions containing them |
| US7376534B2 (en) * | 2004-05-21 | 2008-05-20 | Bea Systems, Inc. | Watches and notifications |
| EP1768986A2 (en) | 2004-06-29 | 2007-04-04 | Amgen Inc. | Furanopyrimidines |
| DK1786273T3 (en) | 2004-08-20 | 2019-02-18 | Prometic Biosciences Ltd | SEQUENTIAL PROTEIN INSULATION AND PURIFICATION PLANS WITH AFFINITY CHROMATOGRAPHY |
| WO2007040557A1 (en) | 2005-09-21 | 2007-04-12 | Surmodics, Inc. | Coatings and articles including natural biodegradable polysaccharides |
| US20080017576A1 (en) | 2006-06-15 | 2008-01-24 | Rensselaer Polytechnic Institute | Global model for optimizing crossflow microfiltration and ultrafiltration processes |
| WO2008008357A1 (en) | 2006-07-11 | 2008-01-17 | Harkness Pharmaceuticals, Inc. | Methods of treating obesity using satiety factors |
| US8231929B2 (en) | 2006-11-09 | 2012-07-31 | Cook Medical Technologies Llc | Medical device coating process |
| US20090038416A1 (en) | 2007-08-07 | 2009-02-12 | Aleta Behrman Bonner | System and method for biological sample collection and analyte detection |
| EP2203051A4 (en) | 2007-09-25 | 2011-09-07 | Abbott Lab | OCTAHYDROPENTAL COMPOUNDS AS CHEMOKIN RECEPTOR ANTAGONISTS |
| US20090163936A1 (en) | 2007-12-21 | 2009-06-25 | Chunlin Yang | Coated Tissue Engineering Scaffold |
| US20100042206A1 (en) | 2008-03-04 | 2010-02-18 | Icon Medical Corp. | Bioabsorbable coatings for medical devices |
| WO2009114725A2 (en) | 2008-03-12 | 2009-09-17 | Children's Hospital Medical Center | Mobilization of hematopoietic stem cells |
| EP2300011A4 (en) | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | THERAPEUTIC PROCESSES AND COMPOUNDS |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| JP2013509170A (ja) | 2009-10-30 | 2013-03-14 | ノボザイムス バイオファーマ デーコー アクティーゼルスカブ | アルブミン変異体 |
| US20120058934A1 (en) | 2010-09-07 | 2012-03-08 | Dmi Acquisition Corp. | Treatment of diseases |
| JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| AU2012323320B2 (en) | 2011-10-10 | 2017-05-11 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| AU2012328605B9 (en) | 2011-10-28 | 2017-08-03 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| JP3176478U (ja) | 2012-04-11 | 2012-06-21 | ネイス株式会社 | 運動用エアートランポリン |
| BR112015017958A2 (pt) | 2013-02-01 | 2017-07-11 | Ampio Pharmaceuticals Inc | métodos para produzir dicetopiperazinas e composições contendo dicetopiperazinas |
| WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| AU2014314053C1 (en) | 2013-08-30 | 2023-11-02 | Takeda Pharmaceutical Company Limited | Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
-
2004
- 2004-05-14 PL PL12005456T patent/PL2537524T3/pl unknown
- 2004-05-14 CN CN2013100492073A patent/CN103191409A/zh active Pending
- 2004-05-14 KR KR1020127020086A patent/KR20120101164A/ko not_active Ceased
- 2004-05-14 EP EP12005458.0A patent/EP2517719B1/en not_active Expired - Lifetime
- 2004-05-14 KR KR1020127014047A patent/KR20120091266A/ko not_active Ceased
- 2004-05-14 CA CA2523467A patent/CA2523467C/en not_active Expired - Lifetime
- 2004-05-14 EP EP12005456.4A patent/EP2537524B1/en not_active Expired - Lifetime
- 2004-05-14 KR KR1020177008646A patent/KR20170038128A/ko not_active Ceased
- 2004-05-14 CN CN201010193231.0A patent/CN101947306B/zh not_active Expired - Fee Related
- 2004-05-14 AU AU2004241101A patent/AU2004241101B2/en not_active Ceased
- 2004-05-14 CN CN201110147118.3A patent/CN102210852B/zh not_active Expired - Fee Related
- 2004-05-14 DK DK12005456.4T patent/DK2537524T3/en active
- 2004-05-14 ES ES12005455T patent/ES2572454T3/es not_active Expired - Lifetime
- 2004-05-14 CN CN201310049222.8A patent/CN103191410B/zh not_active Expired - Fee Related
- 2004-05-14 ES ES12005457.2T patent/ES2575563T3/es not_active Expired - Lifetime
- 2004-05-14 CN CN201410280192.6A patent/CN104095851A/zh active Pending
- 2004-05-14 US US10/846,482 patent/US7732403B2/en not_active Expired - Lifetime
- 2004-05-14 NZ NZ542886A patent/NZ542886A/en not_active IP Right Cessation
- 2004-05-14 EP EP12005455.6A patent/EP2517718B1/en not_active Expired - Lifetime
- 2004-05-14 JP JP2006533125A patent/JP2007500747A/ja active Pending
- 2004-05-14 KR KR1020157016536A patent/KR20150080004A/ko not_active Ceased
- 2004-05-14 CN CN2013100492251A patent/CN103142599A/zh active Pending
- 2004-05-14 KR KR1020057021755A patent/KR20060022659A/ko not_active Ceased
- 2004-05-14 ES ES12005456.4T patent/ES2596180T3/es not_active Expired - Lifetime
- 2004-05-14 EP EP04752368.3A patent/EP1622633B1/en not_active Expired - Lifetime
- 2004-05-14 PT PT120054564T patent/PT2537524T/pt unknown
- 2004-05-14 ES ES12005458.0T patent/ES2579635T3/es not_active Expired - Lifetime
- 2004-05-14 EP EP12005454.9A patent/EP2517721A3/en not_active Withdrawn
- 2004-05-14 CA CA3050734A patent/CA3050734A1/en not_active Abandoned
- 2004-05-14 EP EP12005457.2A patent/EP2517722B1/en not_active Expired - Lifetime
- 2004-05-14 WO PCT/US2004/015340 patent/WO2004103304A2/en not_active Ceased
- 2004-05-14 ES ES04752368.3T patent/ES2572975T3/es not_active Expired - Lifetime
- 2004-05-14 EP EP14175385.5A patent/EP2799114A3/en not_active Withdrawn
- 2004-05-14 HU HUE12005456A patent/HUE031620T2/en unknown
- 2004-05-14 CN CN201210242001.8A patent/CN102727861B/zh not_active Expired - Fee Related
- 2004-05-14 NZ NZ576931A patent/NZ576931A/en not_active IP Right Cessation
-
2005
- 2005-11-14 IL IL171961A patent/IL171961A/en not_active IP Right Cessation
-
2010
- 2010-02-18 US US12/707,958 patent/US8324167B2/en not_active Expired - Fee Related
- 2010-02-18 US US12/707,942 patent/US9707227B2/en not_active Expired - Fee Related
- 2010-04-02 US US12/753,671 patent/US20100190696A1/en not_active Abandoned
- 2010-07-23 AU AU2010203293A patent/AU2010203293B2/en not_active Ceased
- 2010-12-28 JP JP2010292763A patent/JP2011102309A/ja active Pending
-
2011
- 2011-09-28 US US13/247,782 patent/US8183209B2/en not_active Expired - Fee Related
-
2012
- 2012-11-14 US US13/676,932 patent/US8969308B2/en not_active Expired - Lifetime
- 2012-11-14 US US13/676,984 patent/US8513196B2/en not_active Expired - Fee Related
- 2012-11-14 US US13/676,966 patent/US8551953B2/en not_active Expired - Fee Related
- 2012-11-14 US US13/677,007 patent/US8962568B2/en not_active Expired - Lifetime
- 2012-11-16 US US13/679,599 patent/US20130079284A1/en not_active Abandoned
-
2014
- 2014-02-04 IL IL230815A patent/IL230815A/en active IP Right Grant
- 2014-02-25 IL IL231142A patent/IL231142A/en active IP Right Grant
- 2014-04-30 JP JP2014093779A patent/JP6102822B2/ja not_active Expired - Fee Related
-
2015
- 2015-03-03 US US14/636,650 patent/US9730924B2/en not_active Expired - Fee Related
- 2015-04-14 HK HK15103600.9A patent/HK1203056A1/xx unknown
- 2015-04-15 HK HK15103642.9A patent/HK1203164A1/en unknown
-
2017
- 2017-07-06 US US15/642,707 patent/US20180140598A1/en not_active Abandoned
-
2019
- 2019-10-02 US US16/591,322 patent/US10828296B2/en not_active Expired - Fee Related
-
2020
- 2020-10-01 US US17/060,750 patent/US11369598B2/en not_active Expired - Lifetime
-
2022
- 2022-05-23 US US17/751,220 patent/US20220288062A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007500747A5 (enExample) | ||
| US10167313B2 (en) | Selective caspase inhibitors and uses thereof | |
| JPH09512806A (ja) | 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物（ｉｉ） | |
| CN1665784A (zh) | 与细胞凋亡蛋白抑制剂结合的smac蛋白的肽抑制剂 | |
| CN102741269A (zh) | Gadd45β靶向剂 | |
| JP2004521123A5 (enExample) | ||
| CN113816990A (zh) | 修饰的氨基酸及其在adc中的应用 | |
| JPH06508126A (ja) | ボンベシン類似体類 | |
| JPH06506699A (ja) | 抗血栓性ペプチドおよび偽ペプチド | |
| JP4233353B2 (ja) | 医薬組成物 | |
| JP2017518363A5 (enExample) | ||
| JPH07324097A (ja) | インターロイキン６拮抗剤、及びペプチド類または医薬として許容されるその塩類 | |
| CA2215827A1 (en) | O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof | |
| JPH08311098A (ja) | 新規ペプチド類およびそれを含有するインターロイキン６拮抗剤 | |
| JPS6136297A (ja) | カルボキシアルキルジペプチドを製造する方法 | |
| JP2006298927A (ja) | ペプチド | |
| WO2022234867A1 (ja) | Ｍｍｐ７阻害作用を有するスルホンアミド | |
| AU615976B2 (en) | Mercapto-acylamino acid antihypertensives | |
| US9045524B2 (en) | Selective caspase inhibitors and uses thereof | |
| JP5220608B2 (ja) | ２−（アミノメチル）−５−クロロベンジルアミド誘導体および凝固因子Ｘａの阻害剤としてのそれらの使用 | |
| JPH02262595A (ja) | ポリペプチド誘導体 | |
| CN1043134A (zh) | 肽类抗凝剂 | |
| JPH0625288A (ja) | ペプチドまたはその塩 | |
| RU2014116550A (ru) | Гликозилированный полипептид и содержащая его фармацевтическая композиция | |
| JPH05163287A (ja) | ペプチド誘導体 |